benazepril hydrochloride and hydrochlorothiazide
- Product NDC
- 60505-0262
- 11-digit product format
- 605050262
- Labeler code
- 60505
- Product ID
- 60505-0262_c2d78236-13cc-962f-70a9-b1a57e3f3d28
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benazepril hydrochloride and hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA078794
- Marketing category
- ANDA
- Marketing start
- 2014-08-21
- Marketing end
- 2021-07-31
- Substance
- BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-0262-1 | 60505026201 | 100 TABLET in 1 BOTTLE (60505-0262-1) | 100 tablet | 2014-08-21 | 2021-07-31 | No | No | Current |